• Medtronic Chairman and CEO Geoffrey Martha sold 50,000 ordinary shares on Oct. 15, 2026.
• The shares sold for $95 each, leaving Martha with direct ownership of 277,866 ordinary shares.
• The Oct. 16, 2026, filing reported the sale under a Rule 10b5-1 plan adopted July 16, 2026.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Medtronic plc published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001560409-26-000011), on October 16, 2026, and is solely responsible for the information contained therein.